trial
as of 2026-07-01Cerebellar rTMS for the Treatment of Schizophrenic Patients
NCTId NCT01072617
at a glance
— · Completed
Enrollment 8 (actual)
Sponsored by Beth Israel Deaconess Medical Center
Primary completion 2009-04
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
8 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2008-02
Primary completion
2009-04
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
Beth Israel Deaconess Medical CenterLead Sponsor
Investigators
1
Alvaro Pascual-Leone, MD, PhDPrincipal Investigator
Sites
1 total
Boston, United States
Facts & assertions
4 sourced
Enrollment
8
Phase
NA
Primary Completion Date
2009-04
Status
COMPLETED
relationships
The graph out of here
lead_sponsor
indication
indication
indication
investigator